Movement Disorder
Patients with unexplained chorea should be tested for antiphospholipid antibodies
Unexplained chorea, especially among women, should prompt testing for antibodies associated with antiphospholipid syndrome, according to data published in Lupus Science & Medicine.
Positive interim results announced in phase 2 trial of leukoencephalopathy drug
Vigil Neuroscience Inc. has announced positive interim data from a phase 2 proof-of-concept clinical trial of a monoclonal antibody to treat those suffering from adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
Health worse in patients concerned about developing drug-induced movement disorders
Patients from community mental health centers who expressed concerns about developing drug-induced movement disorders tended to report worse health and daily functioning, according to study results presented at NEI Congress.
CV comorbidities not including stroke may be lower in Parkinson’s disease
Patients with Parkinson’s disease had higher rates of stroke and lower rates of CAD and vascular disease risk factors, researchers found.
BLOG: How functional neurology and optometry can work together
by David Rosenthal, DC, FICPA, FIBFN-CND